TBPH icon

Theravance Biopharma
TBPH

Overview Fund Activity

135 hedge funds and large institutions have $512M invested in Theravance Biopharma in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 54 increasing their positions, 32 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
135
Holders Change
+4
Holders Change %
+3.05%
% of All Funds
1.81%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.07%
New
24
Increased
54
Reduced
32
Closed
20
Calls
$3K
Puts
$286K
Net Calls
-$283K
Net Calls Change
-$273K

Top Buyers

1
BlackRock
BlackRock
New York
$45.7M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
$5.55M
3
JFG
Jefferies Financial Group
New York
$3.05M
4
NM
Newtyn Management
New York
$54.6M
5
Morgan Stanley
Morgan Stanley
New York
$6.07M

Top Sellers

1
CCM
Camber Capital Management
Massachusetts
$4.96M
2
NL
Nuveen LLC
North Carolina
$1.33M
3
Millennium Management
Millennium Management
New York
$483K
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
$0
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
$223K
Name Holding Trade Value Shares
Change 		Shares
Change %
CCM
151
Coldstream Capital Management
Washington
– -$21K -2,346 Closed
PHK
152
Point72 Hong Kong
Hong Kong
– -$3.57K -400 Closed
QCG
153
Quadrant Capital Group
Ohio
– -$2.99K -335 Closed
SAM
154
Smartleaf Asset Management
Massachusetts
– -$489 -53 Closed
CA
155
CoreCap Advisors
Michigan
– -$241 -27 Closed
TWD
156
True Wealth Design
Ohio
– -$27 -3 Closed
3 4 5 6
7